News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. stock futures held near flat as reports emerged of an Oman-backed plan to reopen the Strait of Hormuz.
  • Tech shares eased after underwhelming quarterly results from AMD and SpaceX, weighing on risk appetite.
  • Oil futures slipped after a surprise rise in U.S. crude inventories.
  • The Pentagon held an emergency session on reported munitions shortfalls following a call from President Trump.
  • Analysts favor OCBC as the best value-quality pick among Singapore's three big banks.
  • Fortuna posted strong Q2 cash flow and returned $82.1 million to shareholders via buybacks.

Latest Articles

Xeris Biopharma Executive Executes Rule 10b5-1 Stock Sale

Xeris Biopharma Executive Executes Rule 10b5-1 Stock Sale

Beth Hecht, serving as the Chief Legal Officer and Corporate Secretary for Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), has completed a sale of company shares. The transaction, which took place on May 1, 2026, involved the disposal of 16,667 shares of common stock for a total value of $103,805. This move comes at a time when the company is naviga…

At least 11 killed as tourist bus overturns in western Mexico

At least 11 killed as tourist bus overturns in western Mexico

A tourist bus traveling from Jalisco overturned near Amatlán de Cañas in Nayarit on a holiday weekend, killing at least 11 people and injuring 31. Passengers were en route to a recreational center. Emergency teams from Nayarit and Jalisco closed the highway to carry out rescues and begin investigating the cause. The accident highlights recurring fa…

Vaxcyte Executive Executes Stock Sale via Pre-Scheduled Trading Plan

Vaxcyte Executive Executes Stock Sale via Pre-Scheduled Trading Plan

Jim Wassil, the Chief Operating Officer of Vaxcyte, Inc. (NASDAQ: PCVX), has completed a sale of company common stock totaling $127,869. The transaction, which took place on May 1, 2026, involved the disposal of 2,250 shares. These shares were sold at prices ranging from $56.425 to $57.26 per share, representing a weighted average price of $56.831 …

Brown University Halves Stake in Blue Owl Public Private Credit Vehicle

Brown University Halves Stake in Blue Owl Public Private Credit Vehicle

Brown University's $8 billion endowment substantially reduced its holdings in Blue Owl Capital Corp, a publicly traded private credit fund, lowering the stake from 3.2 million shares at the end of 2025 to 1.5 million shares at March 31, according to a 13-F filing. The university kept its roughly 2.6 million shares in Blue Owl's management company. …

GameStop Poised to Make Bid for eBay, Sources Say

GameStop Poised to Make Bid for eBay, Sources Say

GameStop is reportedly preparing an acquisition proposal for eBay and has been accumulating a position in the online marketplace's shares. Market reaction in after-hours trading saw eBay jump roughly 9% while GameStop rose about 3%. Company comments were not immediately available, and a formal proposal could arrive as soon as later this month.

Covenant Logistics Director Executes Stock Sale and Share Gift

Covenant Logistics Director Executes Stock Sale and Share Gift

Recent regulatory filings have disclosed stock transaction activity by D. Michael Kramer, a director at Covenant Logistics Group, Inc. (NASDAQ:CVLG). On April 29, 2026, Mr. Kramer executed two distinct transactions involving the company's Class A Common Stock, consisting of both a market sale and a charitable or gift-based disposition. These moves …

Independence Realty Trust Director Executes Scheduled Stock Sale

Independence Realty Trust Director Executes Scheduled Stock Sale

An SEC filing has revealed that Richard D. Gebert, a director at Independence Realty Trust, Inc. (NYSE:IRT), conducted a sale of company common stock on May 1, 2026. The transaction involved the disposal of 500 shares at a price point of $16.33 per share, resulting in total proceeds of $8,164. This specific divestment was carried out under a pre-es…

Unum Group Executive Sells Nearly $1 Million in Common Stock

Unum Group Executive Sells Nearly $1 Million in Common Stock

An SEC filing has revealed that Elizabeth Claire Ahmed, the Executive Vice President of People & Communications at Unum Group (NYSE: UNM), has executed a sale of company shares. The transaction took place on April 30, 2026, involving the disposal of 12,000 shares of common stock at a price point of $80.14 per share. This move resulted in total proc…

Gentex: Cheap, Cash-Generative Auto-Tech With Operational Optionalities

Gentex: Cheap, Cash-Generative Auto-Tech With Operational Optionalities

Gentex (GNTX) is a market leader in automotive vision and dimmable-glass technologies trading at roughly $4.9B market cap, with P/E ~13, EV/EBITDA ~8.4, and free cash flow north of $450M. The balance sheet is clean (debt-to-equity 0) and the company pays a steady $0.12 quarterly dividend. We like a tactically sized long position into $29 while prot…

Cerebras Pursues Up to $4 Billion in IPO, Eyes Roughly $40 Billion Valuation

Cerebras Pursues Up to $4 Billion in IPO, Eyes Roughly $40 Billion Valuation

Cerebras Systems Inc. is preparing to offer up to $4 billion in an initial public offering and is targeting a valuation near $40 billion, according to people familiar with the matter. The Sunnyvale, California company may begin formal marketing as soon as Monday, and banks involved have received indications of interest exceeding $10 billion. Compan…

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Celcuity Inc. announced positive topline results from the PIK3CA mutant cohort in their Phase 3 VIKTORIA-1 clinical trial evaluating gedatolisib combined with fulvestrant and palbociclib in hormone receptor positive, HER2-negative advanced breast cancer. The trial demonstrated statistically significant and clinically meaningful improvements in prog…

Apple Sees Potential F1 Film Sequel as It Eyes Broader Global TV Role

Apple Sees Potential F1 Film Sequel as It Eyes Broader Global TV Role

Apple senior executive Eddy Cue said a sequel to the Brad Pitt-led F1 film is likely and indicated Apple wants to grow its involvement in Formula One beyond the U.S. after securing exclusive American broadcast rights for the 24-race season. Cue praised the reception to Apple TV's coverage, highlighted ambitions to expand into additional markets, an…